Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
13.93
-0.18 (-1.28%)
At close: Mar 19, 2026, 4:00 PM EDT
13.84
-0.09 (-0.63%)
After-hours: Mar 19, 2026, 7:40 PM EDT
Omada Health Stock Forecast
Stock Price Forecast
The 10 analysts that cover Omada Health stock have a consensus rating of "Buy" and an average price target of $24, which forecasts a 72.29% increase in the stock price over the next year. The lowest target is $17 and the highest is $30.
Price Target: $24 (+72.29%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 9 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $32 → $26 | Buy | Maintains | $32 → $26 | +86.65% | Mar 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $28 → $22 | Strong Buy | Maintains | $28 → $22 | +57.93% | Mar 6, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $27 → $18 | Buy | Maintains | $27 → $18 | +29.22% | Mar 6, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +115.36% | Mar 6, 2026 |
| Barclays | Barclays | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +29.22% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
317.64M
from 260.21M
Increased by 22.07%
Revenue Next Year
380.38M
from 317.64M
Increased by 19.75%
EPS This Year
-0.07
from -0.35
EPS Next Year
0.21
from -0.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 338.4M | 409.0M | |
| Avg | 317.6M | 380.4M | |
| Low | 293.7M | 353.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.1% | 28.7% | |
| Avg | 22.1% | 19.8% | |
| Low | 12.9% | 11.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.16 | 0.44 | |
| Avg | -0.07 | 0.21 | |
| Low | -0.31 | -0.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.